yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..
the smok-e mountain brand's facebook page had been taken down on thursday..